Susan Hasty, Publisher
Table of Contents . . . December 18th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Cancer Vaccine - Combination of inactivated tumor cells and GM-CSF effective against neuroblastomas
Pneumococcal Vaccine - Streptococcus pneumoniae antigens are good candidates for mucosal vaccines
Cancer Therapy - Strong results from Australian cancer vaccine trials
Cancer Vaccine - Carcinoembryonic antigen expressed by head and neck cancer tumors
Genital Herpes - Major vaccine trial launched in women
Influenza Vaccine - Airline flight crews benefit from influenza vaccination
Breast Cancer - University of Alabama to initiate phase I trial of HER-2 vaccine
Dengue Fever - PAHO analyzes social, economic and epidemiological trends
Finance - AIDSVAX developer releases third-quarter financial results
Finance - Allovectin-7 developer announces third-quarter 2002 financial results
Finance - Cost, staff reduction plans underway for vaccine maker
Finance - Qiagen reports third quarter net sales increased 21%
HIV Immunity - Study: Remune antigen with CpG ODN may offer HIV protection
Immune Response - Vaccine and immunotherapy adjuvant technology presented at IDD conference
Immunology - Researcher summarizes the promise of dendritic cells
Influenza - AMA says there's still time to get vaccinated against the flu
Influenza - Preservative-free influenza vaccine available for pediatric use
Measles - Transmission of virus strain successfully interrupted in the Americas
Metastatic Melanoma - Company provides update on Allovectin-7 melanoma program
Metastatic Prostate Cancer - Therion Biologics licenses ICAM-1
Non-Hodgkin Lymphoma - Personalized vaccine being tested
Rubella - Vaccination recommendation changes for pregnant women
Vaccine Supply - Wyeth stops making two vaccines
Vaccinology - NIAID releases 20th anniversary edition of Jordan report on vaccine research
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.